Novel drug targets tumor growth in advanced kidney cancer

Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.

Richard Saltus | Feb. 12, 2020 | harvard

---

~4 mins   

Tags: health-medicine basic-research clear-cell-renal-cell-carcinoma dana-farber-cancer-institute hypoxia-inducible-factor kidney-cancer metastatic-disease mk-6482 nobel-prize phase-iii toni-choueiri tumors william-g-kaelin-jr